# The Preemptive Analgesic Efficacy of Nefopam

> **NCT02561468** · NA · COMPLETED · sponsor: **Seoul National University Bundang Hospital** · enrollment: 94 (actual)

## Conditions studied

- Breast Neoplasm

## Interventions

- **DRUG:** Nefopam
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT02561468
- **Lead sponsor:** Seoul National University Bundang Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2016-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02561468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02561468, "The Preemptive Analgesic Efficacy of Nefopam". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02561468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*